Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating Max-40279-01 with azacitidine for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia; safety, pharmacokinetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Max-40279-01

Snippet

Sponsor: Maxinovel Pty., Ltd. | Conditions: Leukemia, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN